Minimally Invasive Therapies Covidien Products Hemostasis Hemostasis

Overview

The Confidence to Know Bleeding Will Stop

After more than 6 years of dedicated scientific research and development, Medtronic launched the Veriset™ patch. It is designed to help you achieve hemostasis quickly and consistently, in ~1 minute1.

Unique Mode of Action

The Veriset™ patch is placed over the injury, gentle pressure is applied for 30 seconds.

Bleeding has stopped at ~1 minute.

How It Works

Fast & Reliable

The Veriset™ patch works in two ways:

Denaturation of red blood cells, resulting in a lower pH and platelets, which are essential for hemostasis, becoming 'trapped' in the oxidised regenerated  cellulose, both these events result in the expedition of the bodies own natural coagulation cascade.

And secondly once the patch is activated, via the combination of Trilysine and Polyethelyne Glycol, a PEG Hydrogel is formed. This Hydrogel has two effects: firstly to adhere the patch to the tissue and secondly to form a seal across the damaged tissue. 

Both parts together help to ensure high efficacy hemostasis can be achieved.

Click to see by yourself.

Watch Video
veriset_mode_of_action_animation_3c

Easy to Use

Ready to use in both open and laparoscopic procedures with no preparation time([FOOTNOTE=Veriset™ Hemostatic Patch Instructions for Use (IFU).],[ANCHOR=],[LINK=])

Store VerisetTM Hemostatic Patch at room temperature <25oC 2

Easily passes through trocar([FOOTNOTE=Based on internal study #TR1478, Evaluating Veriset™ hemostatic path after laparoscopic liver resection in a porcine model, 2013.],[ANCHOR=],[LINK=])

Not contraindicated in a contaminated or infected environment2

Fast And Reliable

  • 75% of patients achieve hemostasis in approximately 1 minute1
  • Hold for only 30 seconds2
  • Usually only 1 patch is required to stop the bleeding1,2

Increased Patient Safety

  • 100% free of human or animal components, eliminating risk of viral transmission2
  • Absorbed in ~28days, Veriset™ patch can not be mistaken for a tumor recurrence on post operative check up scans
  • Offers bactericidal properties2

Effective

  • Able to withstand high pressure, burst pressure of >200mm Hg, Tachosil® is 46mm Hg
  • Effective in cases of inhibited coagulation, independent of clotting ability([FOOTNOTE=Sponsored preclinical study assessing CV and PV models on animals with inhibited platelet activity (heparin, aspirin, Plavix™*). 2010.],[ANCHOR=],[LINK=])
  • Significantly superior performance compared to TachoSil™*1,([FOOTNOTE=Based on internal test study #COVEUCV0140-CSR, Study to compare the Veriset™ hemostatic patch to TachoSil™* as an adjunct to hemostasis in subjects undergoing cardiovascular surgery. March 2014. Data on file.],[ANCHOR=],[LINK=])

What Our Customers Say

Effective in cases of inhibited coagulation and independent of clotting ability

"The Veriset™ patch does not require a patient to have a perfect coagulopathy." 

"It is easy to handle without any difficulties, even in laparoscopic surgery."

Watch Video

Clinical Evidence

Achieved hemostasis significantly faster than the control device1 

The Veriset™ hemostatic patch is effective in promoting hemostatis and does not elicit any safety concerns.([FOOTNOTE=C. Schuhmacher, J. Pratschke, S. Weiss, S. Schneeberger, A. Mihaljevic, R. Schirren, M. Winkler, N. Emmanouilidis. Safety and effectiveness of a syntheric hemostatic patch for intraoperative soft tissue bleeding. Medical Devices: Evidence and Research; 31 March 2015. 8 167-174.],[ANCHOR=],[LINK=])

Regardless of bleeding severity or surface area, the Veriset™ hemostatic path achieved hemostasis significantly faster than the control device in patients undergoing hepatic resection. It was safe and easy to handle in open hepatic surgery.1

Learn More

Order Information

Click below to learn about the available order options.

Resources

CORPORATE RESOURCES
Minimally Invasive Therapies
© 2018 Medtronic